Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so that I was diagnosed…
clinical trial
Positive Topline Data $31.886M Market Capitalization Windtree Therapeutics Inc. (WINT.Q) announced today positive primary results with istaroxime in rapidly raising systolic blood pressure, the critical clinical objective in treating…
Numinus Wellness (NUMI.T) has moved into the implementation part of their MDMA-assisted psychotherapy trial for post-traumatic stress disorder (PTSD) clinical trial by enrolling and dosing its first volunteer. Numinus…
Digital Medicine Society The world is on fire, inflation is through the roof, and there is a literal war occurring in Ukraine. While I believe it is important…
Forget-Me-Not Whether you believe in the metaphysical or not, there’s no denying the achievements of science. In particular, biotechnology has uncovered significant advancements in the field of medicine. For context,…
Old Memories I have always been a sucker for nostalgia. When I first started writing for Equity Guru, I spent most of my time covering biotechnology companies. Whether they…
Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple…
$140.123M Market Capitalization Numinus Wellness Inc. (NUMI.T) announced today that it has formally submitted its clinical trial application (CTA) to Health Canada for its Phase 1 study, HOPE, on…
Sernova Corp. $435.182M Market Capitaliztion Sernova Corp. (SVA.V) has provided a progress update on the Company’s Phase 1/2 type 1 diabetes (T1D) clinical trial in conjunction with Dr. Piotr…
Fulcrum Therapeutics (FULC.Q) announced positive results today from its ongoing Phase 1 trial with FTX-6058 in healthy adult volunteers. “We are very pleased with the interim results from this…